Impact of intramammary inoculation of inactivated Lactobacillus rhamnosus and antibiotics on the milk microbiota of water buffalo with subclinical mastitis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 08 2018
accepted: 18 12 2018
entrez: 8 1 2019
pubmed: 8 1 2019
medline: 1 10 2019
Statut: epublish

Résumé

Water buffalo mastitis represents a major issue in terms of animal health, cost of therapy, premature culling and decreased milk yeld. The emergence of antibiotic resistance has led to investigate strategies to avoid or reduce antibiotics' based therapies, in particular during subclinical mastitis. The use of Generally Regarded As Safe bacteria (GRAS) such as Lactobacillus rhamnosus to restore the unbalance in mammary gland microbiota could provide potential corrective measures. The aim of this study was to investigate the changes in milk microbiota after the intramammary treatment with inactivated cultures of Lactobacillus rhamnosus of mammary gland quarters naturally affected by subclinical mastitis as compared to antibiotic therapy.A number of 43 quarters affected by subclinical mastitis with no signs of clinical inflammation and aerobic culture positive for pathogens were included in the study. The experimental design was as follows: 11 quarters were treated with antibiotics, 15 with inactivated cultures of Lactobacillus rhmnosus and 17 with PBS as negative control, by means of intrammary injection. Samples were collected at eight time points, pre- (T-29, T-21, T-15, T-7, T0 days) and post- treatment (T1, T2, and T6 days). Microbiological culture and Somatic Cell Count (SCC) were perfomed on all the samples, and microbiota was determined on milk samples collected at T0 and T6 by amplifying the V4 region of 16S rRNA gene by PCR and sequencing using next generation sequencing technique. Treatment with Lactobacillus rhamnosus elicited a strong chemotactic response, as determined by a significant increase of leukocytes in milk, but did not change the microbiological culture results of the treated quarters. For what concerns the analysis of the microbiota, the treatment with Lactobacillus rhamnosus induced the modification in relative abundance of some genera such as Pseudomonas and 5-7N15. As expected, antibiotic treatment caused major changes in microbiota structure with an increase of Methylobacterium relative abundance. No changes were detected after PBS treatment. In conclusion, the present findings demonstrated that the in vivo intrammmary treatment with Lactobacillus rhamnosus has a transient pro-inflammatory activity by increasing SCC and is capable to modify the microbiota of milk after six days from inoculation, albeit slightly, even when the bacterial cultures were heat inactivated. Further studies are necessary to assess the potential use of this GRAS as supportive therapy against mastitis.

Identifiants

pubmed: 30615691
doi: 10.1371/journal.pone.0210204
pii: PONE-D-18-25255
pmc: PMC6322744
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210204

Déclaration de conflit d'intérêts

AC is affiliated with Vet Genomic. This commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Infect Immun. 2008 Apr;76(4):1340-8
pubmed: 18227169
Mol Biosyst. 2016 Jul 19;12(8):2359-72
pubmed: 27216801
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
PLoS One. 2017 Sep 5;12(9):e0184218
pubmed: 28873396
Res Microbiol. 2010 Oct;161(8):673-80
pubmed: 20600855
J Dairy Res. 2004 May;71(2):162-8
pubmed: 15190943
J Dairy Sci. 2006 Mar;89(3):998-1003
pubmed: 16507694
PLoS One. 2015 Dec 29;10(12):e0144831
pubmed: 26713450
Curr Microbiol. 2016 Apr;72(4):377-82
pubmed: 26687332
Lett Appl Microbiol. 2017 May;64(5):343-349
pubmed: 28178767
PLoS One. 2012;7(10):e47671
pubmed: 23082192
J Dairy Res. 2012 Feb;79(1):84-92
pubmed: 22077995
J Clin Microbiol. 2014 May;52(5):1317-21
pubmed: 24430456
PLoS One. 2013 Apr 25;8(4):e61959
pubmed: 23634219
J Dairy Res. 2008 Aug;75(3):365-73
pubmed: 18680622
J Dairy Sci. 2011 Oct;94(10):4863-77
pubmed: 21943738
J Dairy Res. 2013 Feb;80(1):28-35
pubmed: 23199568
Vet Microbiol. 2015 Jan 30;175(1):105-13
pubmed: 25475851
J Med Microbiol. 2017 Dec;66(12):1798-1810
pubmed: 29134942
Front Vet Sci. 2018 Jan 08;4:237
pubmed: 29359135
PLoS One. 2018 Mar 21;13(3):e0193671
pubmed: 29561873
Microbiome. 2017 Jul 12;5(1):74
pubmed: 28701174
Nat Microbiol. 2017 Aug 24;2:17121
pubmed: 28836573
J Dairy Sci. 2014 Nov;97(11):6964-9
pubmed: 25242419
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Rev Sci Tech. 2017 Apr;36(1):217-226
pubmed: 28926014
J Dairy Sci. 2016 Mar;99(3):2288-2296
pubmed: 26774727
J Dairy Res. 2009 Aug;76(3):340-8
pubmed: 19445831
Vet Microbiol. 2017 May;204:174-179
pubmed: 28532798
J Dairy Sci. 2017 Jan;100(1):479-492
pubmed: 27837977
PLoS One. 2015 Nov 25;10(11):e0142973
pubmed: 26606430
Front Microbiol. 2018 Jul 24;9:1661
pubmed: 30087667
J Dairy Sci. 1991 Sep;74(9):2976-81
pubmed: 1779053
Appl Environ Microbiol. 2013 Feb;79(3):877-85
pubmed: 23183972
PLoS One. 2015 Nov 20;10(11):e0142717
pubmed: 26588070
PLoS One. 2017 Sep 19;12(9):e0184710
pubmed: 28926595
J Dairy Sci. 2013 Aug;96(8):5129-45
pubmed: 23769372
PLoS One. 2014 Jan 20;9(1):e85904
pubmed: 24465777
Appl Environ Microbiol. 2015 Dec 11;82(4):1173-1182
pubmed: 26655757
Vet Res. 2017 Apr 17;48(1):25
pubmed: 28412972
mSystems. 2018 Nov 20;3(6):
pubmed: 30505944
FEMS Microbiol Rev. 2011 Sep;35(5):901-11
pubmed: 21707669
Vet Q. 2007 Mar;29(1):18-31
pubmed: 17471788
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Front Cell Infect Microbiol. 2014 Mar 05;4:29
pubmed: 24634890
Vet Microbiol. 2013 Dec 27;167(3-4):592-9
pubmed: 24080351
J Agric Food Chem. 2017 Jun 14;65(23):4744-4754
pubmed: 28510450
Vet Clin North Am Food Anim Pract. 2012 Jul;28(2):165-85
pubmed: 22664201
J Dairy Res. 2008 Aug;75(3):374-84
pubmed: 18680623
Antimicrob Agents Chemother. 1983 Nov;24(5):771-6
pubmed: 6660851

Auteurs

Carlotta Catozzi (C)

Dipartimento di Medicina Veterinaria, Università di Milano, Milano, Italy.

Anna Cuscó (A)

Vetgenomics. Ed Eureka. PRUAB. Campus UAB, Barcelona, Spain.

Cristina Lecchi (C)

Dipartimento di Medicina Veterinaria, Università di Milano, Milano, Italy.

Esterina De Carlo (E)

Istituto Zooprofilattico Sperimentale del Mezzogiorno, National Reference Centre for Hygiene and Technologies of Water Buffalo Farming and Productions, Salerno, Italy.

Domenico Vecchio (D)

Istituto Zooprofilattico Sperimentale del Mezzogiorno, National Reference Centre for Hygiene and Technologies of Water Buffalo Farming and Productions, Salerno, Italy.

Alessandra Martucciello (A)

Istituto Zooprofilattico Sperimentale del Mezzogiorno, National Reference Centre for Hygiene and Technologies of Water Buffalo Farming and Productions, Salerno, Italy.

Luisa D'Angelo (L)

Istituto Zooprofilattico Sperimentale del Mezzogiorno, National Reference Centre for Hygiene and Technologies of Water Buffalo Farming and Productions, Salerno, Italy.

Olga Francino (O)

Molecular Genetics Veterinary Service (SVGM), Veterinary School, Universitat Autònoma de Barcelona, Barcelona, Spain.

Armand Sanchez Bonastre (A)

Molecular Genetics Veterinary Service (SVGM), Veterinary School, Universitat Autònoma de Barcelona, Barcelona, Spain.

Fabrizio Ceciliani (F)

Dipartimento di Medicina Veterinaria, Università di Milano, Milano, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH